Skip to content Skip to main menu


Clinical study of XanthigenⓇ

  • Subjects: 151 women with obesity,premenopausal and non-diabetic, mean age 36.7 years, average weights 93.8±2.2kg
  • Intake: XanthigenⓇ600mg
  • Period: 16 weeks
Increase REE
Reduction of Body Fat
Reduction of Waist
Reduction of Visceral fat
Weight Loss

Effect of Xanthigen® on body weight in patients with non-alcoholic fatty liver disease (a) and in normal liver fat (b).
Weight decreased in both groups from 6 to 8 weeks after ingestion of Xanthigen®.

(a) Weights chnage in patients with non-alcoholic fatty liver disease

(b)Weights change in normal liver fat group

※Arrows indicate the time(weeks)when the first statistically signficant differences in weight loss between XanthigenⓇ and placebo groups (p<0.05)were noted.

Effects of XanthigenⓇ on resting energy expenditure (REE,kJ/MIN)in obese non-diabetic female voluteers with NAFLD.

  • In the test for measuring resting energy expenditure(REE) consumtion, REE was significantly increased compared to the control group when XantigenⓇ 600mg was consumed.

PSO,pomegrante seed oil, BSE, brown seaweed extract; NAFLD, non-alcoholic fatty liver disease.


Diabetes, Obesity and Metabolism (2010) 12, 1:72-81 lDiabetes,Obesity and Metabolism(2010)12,1:72:81